JP2016500250A5 - - Google Patents

Download PDF

Info

Publication number
JP2016500250A5
JP2016500250A5 JP2015543148A JP2015543148A JP2016500250A5 JP 2016500250 A5 JP2016500250 A5 JP 2016500250A5 JP 2015543148 A JP2015543148 A JP 2015543148A JP 2015543148 A JP2015543148 A JP 2015543148A JP 2016500250 A5 JP2016500250 A5 JP 2016500250A5
Authority
JP
Japan
Prior art keywords
amino acid
protein
modified protein
acid residues
reference secreted
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2015543148A
Other languages
English (en)
Japanese (ja)
Other versions
JP2016500250A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2013/071091 external-priority patent/WO2014081884A1/en
Publication of JP2016500250A publication Critical patent/JP2016500250A/ja
Publication of JP2016500250A5 publication Critical patent/JP2016500250A5/ja
Withdrawn legal-status Critical Current

Links

JP2015543148A 2012-11-20 2013-11-20 改変された分泌タンパク質及び方法 Withdrawn JP2016500250A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201261728427P 2012-11-20 2012-11-20
US61/728,427 2012-11-20
PCT/US2013/071091 WO2014081884A1 (en) 2012-11-20 2013-11-20 Engineered secreted proteins and methods

Publications (2)

Publication Number Publication Date
JP2016500250A JP2016500250A (ja) 2016-01-12
JP2016500250A5 true JP2016500250A5 (OSRAM) 2017-01-19

Family

ID=50776536

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2015543148A Withdrawn JP2016500250A (ja) 2012-11-20 2013-11-20 改変された分泌タンパク質及び方法

Country Status (7)

Country Link
US (1) US20150307562A1 (OSRAM)
EP (1) EP2922416A4 (OSRAM)
JP (1) JP2016500250A (OSRAM)
CN (1) CN104936466A (OSRAM)
CA (1) CA2892021A1 (OSRAM)
HK (1) HK1214739A1 (OSRAM)
WO (1) WO2014081884A1 (OSRAM)

Families Citing this family (45)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2913876A1 (en) * 2013-05-31 2014-12-04 Dsm Ip Assets B.V. Microorganisms for diterpene production
EP3027742B1 (en) 2013-07-29 2019-11-20 Danisco US Inc. Variant enzymes
WO2015048334A2 (en) * 2013-09-25 2015-04-02 Pronutria, Inc. Edible species nutritive polypeptides and methods of production and use thereof
GB201401699D0 (en) * 2014-01-31 2014-03-19 Dupont Nutrition Biosci Aps Protein
CN103881994B (zh) * 2014-04-14 2020-03-27 中国农业科学院生物技术研究所 一种具有高转糖苷活性的β-半乳糖苷酶突变体及其制备方法和应用
FR3022558B1 (fr) * 2014-06-20 2019-01-25 Proteus Variants d'exoglucanases a activite amelioree et leurs utilisations
DK3197472T3 (da) * 2014-09-22 2021-10-18 Tanea Medical Ab Rekombinante phe-frie proteiner til anvendelse i behandlingen af phenylketonuri
CN107135653A (zh) * 2014-10-01 2017-09-05 安迅生物制药公司 大肠杆菌素变体
WO2016077457A1 (en) * 2014-11-11 2016-05-19 Clara Foods Co. Methods and compositions for egg white protein production
AU2015366380B2 (en) 2014-12-19 2021-07-22 Novozymes A/S Compositions comprising polypeptides having xylanase activity and polypeptides having arabinofuranosidase activity
GB201501565D0 (en) * 2015-01-30 2015-03-18 Dupont Nutrition Biosci Aps Method
WO2016149482A2 (en) * 2015-03-17 2016-09-22 Vanderbilt University Cs21 and lnga protein vaccines
CA2987164C (en) * 2015-06-26 2023-09-19 Novozymes A/S Method for producing a coffee extract
US10188135B2 (en) * 2015-11-04 2019-01-29 Stokley-Van Camp, Inc. Method for inducing satiety
US11167016B2 (en) 2016-02-18 2021-11-09 Amanoenzyme Inc. Intestinal flora improvement agent
WO2017202966A1 (en) 2016-05-24 2017-11-30 Novozymes A/S Polypeptides having alpha-galactosidase activity and polynucleotides encoding same
WO2017202979A1 (en) * 2016-05-24 2017-11-30 Novozymes A/S Polypeptides having alpha-galactosidase activity and polynucleotides encoding same
WO2017202997A1 (en) * 2016-05-24 2017-11-30 Novozymes A/S Compositions comprising polypeptides having galactanase activity and polypeptides having beta-galactosidase activity
US11273455B2 (en) 2016-06-27 2022-03-15 Novozymes A/S Method of dewatering post fermentation fluids
CA3029113A1 (en) * 2016-07-08 2018-01-11 Novozymes A/S Xylanase variants and polynucleotides encoding same
CN109477126B (zh) * 2016-07-19 2023-06-20 三得利控股株式会社 罗汉果醇或罗汉果醇糖苷的生产方法
ME03510B (me) 2016-09-01 2020-04-20 Metax Inst Fuer Diaetetik Gmbh Protein bez fenilalanina za liječenje pku
EA201891926A1 (ru) * 2017-02-03 2019-04-30 Киверди, Инк. Микроорганизмы и искусственные экосистемы для производства белка, продуктов питания и полезных побочных продуктов из субстратов c1
EP3592429A1 (en) * 2017-03-06 2020-01-15 DuPont Nutrition Biosciences ApS Novel fungal fucosidases and their use in preventing and/or treating a pathogenic infection in an animal
AU2019325329A1 (en) * 2018-08-21 2021-04-08 Clara Foods Co. Modification of protein glycosylation in microorganisms
US12234464B2 (en) 2018-11-09 2025-02-25 Ginkgo Bioworks, Inc. Biosynthesis of mogrosides
MX2021011361A (es) * 2019-03-19 2021-10-13 Bayer Cropscience Lp Proteinas de fusion, bacterias recombinantes y fragmentos de exosporios para la salud de las plantas.
US12096784B2 (en) 2019-07-11 2024-09-24 Clara Foods Co. Protein compositions and consumable products thereof
DK3997118T3 (da) 2019-07-11 2025-03-24 Clara Foods Co Drikkevaresammensætning, der indeholder rekombinant ovomucoid-protein
US10927360B1 (en) 2019-08-07 2021-02-23 Clara Foods Co. Compositions comprising digestive enzymes
MX2022002834A (es) 2019-09-16 2022-04-06 Novozymes As Polipeptidos con actividad beta-glucanasa y polinucleotidos que los codifican.
WO2021185969A1 (en) * 2020-03-18 2021-09-23 Numaferm Gmbh Variants of hlya and uses thereof
EP3892290A1 (en) * 2020-04-08 2021-10-13 NUMAFERM GmbH Variants of hlya and uses thereof
WO2021207679A1 (en) * 2020-04-10 2021-10-14 Liberty Biosecurity, Llc Polypeptide compositions and uses thereof
EP4291634A4 (en) * 2021-02-10 2025-01-01 Novozymes A/S POLYPEPTIDES HAVING PECTINASE ACTIVITY, POLYNUCLEOTIDES FOR ENCODING THEM AND USES THEREOF
EP4314242A4 (en) * 2021-03-25 2025-01-22 Bio-Cat, Inc. MIXTURES OF FUNGAL PROTEASES AND THEIR USES
CN114015678A (zh) * 2021-09-30 2022-02-08 中南民族大学 一种球形赖氨酸芽孢杆菌C3-41来源的氨肽酶Amp0279及其重组菌株和应用
MX2021014268A (es) * 2021-11-19 2022-02-16 Univ Mexico Nac Autonoma Proteina optimizada que comprende los aminoacidos esenciales para la nutricion humana.
US20230281444A1 (en) * 2022-03-04 2023-09-07 Cella Farms Inc Computational system and algorithm for selecting nutritional microorganisms based on in silico protein quality determination
AU2023256853A1 (en) 2022-04-20 2024-08-22 Novozymes A/S Process for producing free fatty acids
WO2023215798A1 (en) * 2022-05-04 2023-11-09 Locus Biosciences, Inc. Phage compositions for escherichia comprising crispr-cas systems and methods of use thereof
AU2023272468A1 (en) 2022-05-14 2024-11-14 Novonesis Plant Biosolutions A/S Compositions and methods for preventing, treating, supressing and/or eliminating phytopathogenic infestations and infections
CN115160420B (zh) * 2022-06-24 2023-06-02 西南大学 盔形毕赤酵母scp类分泌蛋白及其应用
WO2024220717A1 (en) * 2023-04-20 2024-10-24 Ginkgo Bioworks, Inc. Biosynthesis of mogrosides
WO2025155915A1 (en) * 2024-01-17 2025-07-24 Anagram Therapeutics, Inc. Methods and compositions for treating congenital sucrase-isomaltase deficiency

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6800726B1 (en) * 1996-11-01 2004-10-05 Pioneer Hi-Bred International, Inc. Proteins with increased levels of essential amino acids
AR017831A1 (es) * 1997-12-10 2001-10-24 Pioneer Hi Bred Int Metodo para alterar la composicion de aminoacidos de una proteina nativa de interes, proteina elaborada, y polinucleotido
US20060159724A1 (en) * 2000-08-08 2006-07-20 Bell Stacey J Nutritional supplement for the management of weight
WO2003025153A2 (en) * 2001-09-17 2003-03-27 Monsanto Technology, Llc Enhanced proteins and methods for their use
US7273738B2 (en) * 2002-10-01 2007-09-25 Novozymes A/S Family GH-61 polypeptides
CN1557475A (zh) * 2004-02-04 2004-12-29 高春平 美容、减肥营养组合物
EP2327316B1 (en) * 2009-11-29 2016-11-16 Premier Nutrition Corporation Method of enhancing muscle protein synthesis
CA2786001A1 (en) * 2009-12-31 2011-07-07 Pioneer Hi-Bred International, Inc. Engineering plant resistance to diseases caused by pathogens
EP2703484A4 (en) * 2011-03-24 2014-12-31 Asahi Glass Co Ltd TRANSFORMANT FROM YEAST OF ART SCHIZOSACCHAROMYCES, METHOD OF MANUFACTURING THEREOF, PROCESS FOR THE PREPARATION OF BETA-GLUCOSIDASE AND METHOD FOR THE DECOMPOSITION OF CELLULOSE
SG10201604464SA (en) * 2012-03-26 2016-07-28 Axcella Health Inc Charged nutritive proteins and methods

Similar Documents

Publication Publication Date Title
JP2016500250A5 (OSRAM)
HK1206764A1 (en) Nutritive proteins and methods
HK1214739A1 (zh) 工程化的分泌蛋白质和方法
HK1206370A1 (en) Charged nutritive proteins and methods
NZ628126A (en) Histidyl-trna synthetases for treating autoimmune and inflammatory diseases
WO2018004308A3 (ko) 신규 내열성 과당-6-인산-3-에피머화 효소 및 이를 이용한 알룰로스 제조방법
JP2015501656A5 (OSRAM)
RU2019108268A (ru) Варианты химозина с улучшенными молокосвертывающими свойствами
IN2014CN00414A (OSRAM)
EA201190326A8 (ru) Полипептиды гормона роста и способы их получения и применения
WO2013151670A3 (en) Modified polynucleotides for the production of nuclear proteins
RU2017104529A (ru) Композиции neisseria meningitidis и способы их применения
RU2014143031A (ru) Фрагменты питательных белков и способы их применения
EP3670536A3 (en) Recombinant tnf ligand family member polypeptides with antibody binding domain and uses thereof
WO2013040093A3 (en) Glucagon-like peptide-2 compositions and methods of making and using same
JP2015212284A5 (OSRAM)
MX2011008094A (es) Polipeptidos recombinantes extendidos y composiciones que comprenden los mismos.
JP2015518470A5 (OSRAM)
JP2014000092A5 (OSRAM)
MX2024010472A (es) Polipeptidos que enlazan adamts5, mmp13 y agrecano.
HK1206763A1 (en) Charged nutritive fragments, proteins and methods
MX2012005864A (es) Proteinas de enlace al antígeno anti-orai 1 y usos de las mismas.
HK1206762A1 (en) Nutritive fragments and proteins with low or no phenylalanine and methods
JP2011125329A5 (OSRAM)
WO2010115995A3 (en) Improved amino acid sequences directed against il-6r and polypeptides comprising the same for the treatment of il-6r related diseases and disorders